financetom
Business
financetom
/
Business
/
Amplify Energy Q3 net loss widens due to impairment charges
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amplify Energy Q3 net loss widens due to impairment charges
Nov 5, 2025 3:08 PM

Overview

* Amplify Q3 adjusted revenue and EBITDA miss analyst expectations

* Company reports Q3 net loss due to impairment charge related to asset divestitures

* Amplify divests Oklahoma and East Texas assets for $220 mln to reduce debt

Outlook

* Amplify expects to close asset divestitures in Q4 2025, using proceeds to reduce debt

* Amplify sees potential cash flow increase from CCUS initiatives at Bairoil

Result Drivers

* ASSET DIVESTITURES - Amplify divested Oklahoma and East Texas assets for $220 mln to reduce debt and simplify portfolio

* BETA DRILLING SUCCESS - Successful drilling at Beta with promising initial results from new wells

* BAIROIL COST SAVINGS - New CO2 initiatives at Bairoil projected to save $10 mln annually in lease operating expenses

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $64.24

Revenue mln

Q3 Miss $66.40 $74.50

Adjusted mln mln (2

Revenue Analysts

)

Q3 Miss -$6 mln $5.10

Adjusted mln (1

Net Analyst)

Income

Q3 Net -$21 mln

Income

Q3 Miss $20.30 $24.40

Adjusted mln mln (2

EBITDA Analysts

)

Q3 Basic -$0.52

EPS

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas exploration and production peer group is "buy"

* Wall Street's median 12-month price target for Amplify Energy Corp ( AMPY ) is $8.50, about 47.1% above its November 4 closing price of $4.50

* The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NewGenIVF Locks In Long-Term Financing To Fuel Its Ambitions, Stock Jumps
NewGenIVF Locks In Long-Term Financing To Fuel Its Ambitions, Stock Jumps
Nov 19, 2024
NewGenIvf Group Limited ( NIVF ) shares are trading higher premarket on Monday after the company inked a binding term sheet with White Lion Capital for a $100 million equity line of credit, expandable to $500 million. As per the term sheet, NewGen can sell up to $100 million in common stock to White Lion over an initial 36-month period....
Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
Nov 19, 2024
08:30 AM EST, 11/18/2024 (MT Newswires) -- Eli Lilly's ( LLY ) Zepbound and Novo Nordisk's ( NVO ) Wegovy are mostly covered by US government health plans than by commercial ones, Reuters reported Monday, citing an analysis by the Leverage consulting firm. Medicaid programs for low-income families are the single biggest source of coverage for new weight-loss drugs, giving...
Walmart stock set for best year since 1999 as profits jump
Walmart stock set for best year since 1999 as profits jump
Nov 19, 2024
(Reuters) - Walmart ( WMT ) shares are set for their best yearly gains in over two decades as the retail behemoth's low prices for everyday essentials give it an edge over competitors facing weak demand from budget-conscious consumers. The stock has gained about 60% so far this year, outstripping gains of about 13% in the S&P 500 Consumer Staples...
Viaro CEO accused in UK lawsuit of forging documents to steal millions
Viaro CEO accused in UK lawsuit of forging documents to steal millions
Nov 19, 2024
Nov 18 (Reuters) - The CEO of an independent British oil producer which is buying North Sea assets owned by Shell and Exxon Mobil ( XOM ) is being sued by his former employer for allegedly forging documents to steal substantial sums. Viaro Energy CEO Francesco Mazzagatti is accused by Singapore-based company Alliance Petrochemical Investment of being involved in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved